Journal: Genes & Diseases
Article Title: E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease
doi: 10.1016/j.gendis.2023.02.051
Figure Lengend Snippet: The E674Q mutation facilitates the fragmentation of APP by BACE1 in vitro and in vivo . (A) Western blot analysis of HEK293 cells transfected with wild-type (WT) APP, APP E674Q, and APP with the Swedish mutation. (B, C) The levels of C99 and C83 fragments were increased in cells transfected with APP E674Q and APPswe. (D, H) ELISA quantification of the concentrations of Aβ40 (D) and Aβ42 (H) in conditioned medium from HEK293 cells transfected with wild-type and mutant APP. Data are presented as mean ± S.E.M. P < 0.01, one-way ANOVA. (E) Western blot analysis of AAV-mediated injection mice with APPwt, APPE674Q, and APPswe (Y188, ab32136, Abcam). (F, G) The levels of APP and C99 fragment were increased in mice hippocampus injected with AAV-APPE674Q and AAV-APPswe. (I–O) Behavioral experiments 6 months after the mice were injected. In the novel object recognition test, DR2 of APPE674Q animals was less than the control ( P < 0.05; J, K); in the Y maze test, APPswe ( P < 0.05) and APPE674Q ( P < 0.01) had a significant difference from the control but no noticeable difference from APPwt (L); in the Barnes maze test, the two APP mutation groups show a potentially faster learning trend than APPwt group (M, N); in the testing trail, APPswe ( P < 0.01) group had a noticeable shorter latency to escape than APPwt group (O).
Article Snippet: Adeno-associated virus vectors (AAVrh.9) encoding human mutant full-length APPswe, APPE674Q, APPwt, and empty control were purchased from Sangon Biotech, China.
Techniques: Mutagenesis, In Vitro, In Vivo, Western Blot, Transfection, Enzyme-linked Immunosorbent Assay, Injection, Control